Key Takeaways
- A seasonally wrecked quarter, not a structural break: Sales returns surged 50% to ₹150 cr and B2C volumes were flat as a dry start then torrential rain destroyed application windows and crop. Management frames this as a one-off weather disaster, not a demand problem.
- Gross margin improved despite the top-line mess: The shift toward Focus Maharatna and Maharatna products lifted gross profit, validating the portfolio strategy even in a quarter where field promotion costs ate the benefit at the EBITDA line.
- Inventory overshoot is the open wound: Inventory crossed ₹700 cr against a year-end target of ~₹600 cr and is headed to ₹800 cr as new-season purchases begin. Management calls this normal but concedes the original target “looks difficult” and offers no revised timeline.
- The export and B2B order book is full through March: Export orders are completely booked and B2B rabi orders are flowing, giving a visible floor under H2 revenue even if domestic B2C recovery remains weather-dependent.
- What to watch next quarter: Whether the delayed rabi cycle converts the “positive mood” into actual volume growth, whether inventory peaks at ₹800 cr or drifts higher, and whether the new COO’s manufacturing mandate produces a credible inventory-normalization path.
The Quarter’s Damage: Weather, Returns, and Flat Volumes
- A double weather hit destroyed the application season: The first 20 days of the quarter were dry, then heavy rainfall disrupted agronomic activities, restricted field access, and caused excess-moisture crop damage across major crops. The harvest season was delayed and agrochemical demand stayed subdued.
- Key herbicide applications were simply missed: Products for cotton, paddy, sugarcane, maize, and soya beans could not be spread during their peak window because of the dry-then-wet pattern. Management says there were “good returns” but no meaningful volume growth in Focus Maharatna and Maharatna categories.
- Sales returns jumped to ₹150 cr from ₹100 cr last year: Management attributes the 50% increase entirely to season failure. The stated policy is to lift back everything from the market rather than leave unsold stock in the channel, then furnish fresh material for the new season.
- B2C volumes were flat; all growth came from B2B and exports: The domestic branded business merely maintained sales, while the international and institutional books carried the quarter.
- Potato sowing suffered patchy losses: Sowing happened in Northern India, then rainfall forced resowing in small patches. Management says this is localized, not statewide.
Rajesh Aggarwal: “When the time gets tough, the tough gets going. At Insecticides, we are not just building products, we are building trust, strengthening farmer prosperity and shaping the future of Indian agriculture.”
Portfolio Strategy: The Maharatna Shift Is Working, Even Now
- Gross margin improved on mix, not volume: The sale of Maharatna products and improved profit in the generic segment drove the gross profit increase, even as overall revenue suffered. This is the core thesis: shift the mix toward higher-margin innovative products and let the portfolio carry margins through cycles.
- Focus Maharatna products now 65% of own-technicals, with a 70% target: Management expects to cross 70% in the next 2 to 3 years. The entire organization — regulatory, registration, development, sales, and production — is being aligned to support this shift.
- New products are filling portfolio gaps crop by crop: The company is working toward a 100% solution under the Tractor brand for all major crops, with particular focus on specialty herbicides because they sell regularly in Q1. Gaps are identified based on farmer needs and marketplace whitespace.
- Off-patent advantage has shrunk from 2–3 years to 6 months: The competitive window on an off-patent molecule launch has collapsed. The response is to register new formulations with IP rights: Torry launched 3 years ago, Torry Super (a mixture) last year; Mission launched 2 years ago, Centran SE and Centran WG now in market.
- Backward integration is a continuous, stepwise process: The company develops technology from the basic stage, then decides which step to start manufacturing based on market competition. It may begin at n-1 or n-2 and slowly move to n-4, n-5, or the basic stage. Both Chopanki and the new L&T-built Dahej plant are executing this molecule by molecule.
Rajesh Aggarwal: “In the past, whenever I used to launch an off-patented molecule, I used to get the advantage of 2-3 years without competition. Nowadays, competition comes in 6 months.”
Inventory: The Number That Worries
- Inventory crossed ₹700 cr against a ~₹600 cr year-end target: The deviation is driven by purchases for the new January–June season that must begin now. Management says inventory may rise further to ₹800 cr, which it characterizes as normal for building new-season stock.
- The original ₹600 cr target is effectively abandoned: When asked directly whether the company is on track, management answered “Looks difficult” and offered no revised target or timeline for normalization. The commitment is only that inventory “will correct in the time to come.”
- The working-capital squeeze is visible in the P&L: Financial costs rose due to tough market conditions, and debtor recovery is “somewhat slow,” adding pressure to the PAT line.
Rajesh Aggarwal: “So, yes, we have suffered on the inventory path which will correct in the time to come forward.”
Field Force, Costs, and the Bet That Didn’t Pay Off
- Field staff was nearly doubled on high expectations: The company expanded its field force from the normal 750–800 to almost 1,500 during peak season and continued activities through September, supported by digitization and learning management software.
- The early rains created optimism that the weather then crushed: Management had high expectations for the year when rains arrived early. The drought that followed, then continuous rainfall, shattered those expectations. The field promotion spend was committed before the season turned.
- Over 100,000 farmers were reached despite adverse conditions: The team organized over 9,000 farmer meetings, over 5,000 demonstrations, and field days showcasing value delivered. Management says this strengthened demand visibility and created product pull even under adverse conditions.
- Other expenses and employee costs rose, subduing EBITDA: The gross margin gain was consumed by the elevated field promotion activity and staff costs, leaving EBITDA roughly in line.
- A “tail cutting” exercise is ongoing alongside the new launches: Over the past 3 years, the company has worked on product range, product profiles, market profiling, team setting, and market setting. Sunset technologies are moving out while a new range enters. Management says the quarter suffered but the 13% profit trajectory is intact.
Rajesh Aggarwal: “We are trying. This quarter, we have suffered. But yes, if we look at 1 or 2 or 3 years, then I can say that we are back on our 13% profit trajectory and we’ll take off from here.”
New Launches, Partnerships, and the Manufacturing Build-Out
- Five new products launched during the season, two in Q2: Altair, a patented pre-emergent herbicide for paddy developed by Nissan Chemical Corporation Japan and exclusively marketed by IIL in India, and Sparcle, a broad-spectrum insecticide for brown plant hopper designed with advanced chemistry from Corteva.
- The Corteva collaboration is flagged as a milestone: IIL and Corteva reaffirmed a joint commitment to delivering science-backed, performance-oriented crop protection solutions. More products are expected from this collaboration.
- Three additional launches filled out the portfolio: Amuse (a patented fungicide developed by IIL), Centran SC (an insecticide, the next level of Mission based on CTPR), and Brahmos (an insecticide from IIL’s own technical).
- Million, the rice herbicide, is now backed by in-house technical: IIL made Pyroxasulfone, the active ingredient, in large quantities on its own this year, which improved B2B sales.
- A new COO has been hired to run the expanding manufacturing footprint: Mr. Devendra Ray, with over 35 years of experience and significant time at PI Industry, is now responsible for all manufacturing activities, expansions, and supply chain management.
- Three plant expansions are underway, and a new SEZ facility is being planned: Dahej formulation expansion is in progress, the Sotanala plant is in full expansion, and the company is thinking of setting up a new facility in an SEZ. CRAM discussions with large global companies are also active.
Rajesh Aggarwal: “So, with so much activities around, and also we are in talks with many large companies of the world to do some CRAM activities or some other activities together. So, we thought that this is the right time to engage a professional who can handle these activities well and who has got a good experience.”
H2 Outlook: Rabi, Exports, and the Recovery Bet
- The extended monsoon was a disaster for Kharif but a gift for Rabi: Excess rainfall caused farmer yield losses across maximum crops in Kharif, but it left ample soil moisture. Wheat sowing is expected to increase across the country, pulses sowing is rising, and a possible surge in paddy sowing is anticipated. Dams are full.
- The entire crop cycle is delayed by almost a month: Herbicides on maize, wheat, potatoes, sugarcane, pulses, gram, and rice in southern India are about to start, followed by insecticides and fungicides. Momentum is expected to return, just later than normal.
- Management expects reasonable H2 recovery, led by specific products: Shinwa (Nissan’s portfolio, IIL’s number-one product) and Torry Super (a maize herbicide, patented by IIL) are expected to perform well in H2.
- The export order book is full through March, with fresh orders still arriving: All export orders have been received, and the B2B order book has fresh orders for November and December. Orders for the last quarter will begin being taken after a while.
- Kaeros brand sales are in a trial year: The brand sales network is being established in H2. This year is a seeding year; next year is the one to watch. Management is confident Kaeros will cross ₹100 cr without worries.
- Export revenue is confidently pegged at ₹150 cr this year: Management initially declined to give numbers, then stated ₹150 cr is the target they are trying to achieve again.
Rajesh Aggarwal: “When something comes as a disaster, it also has positive side. So, the extended rainfall has now given a good opportunity for the Rabi season or the second season because there is a lot of moisture available in soil…”
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Profit trajectory | Return to 13% profit trajectory and grow continuously from here | Over the next 1–3 years |
| Focus Maharatna own-technicals share | Cross 70% (from current 65%) | Next 2–3 years |
| Export revenue | Touch ₹150 cr | This fiscal year |
| Kaeros brand sales | Cross ₹100 cr | This fiscal year (trial/seeding year) |
| New AI launches | 3–4 new AIs at least every year, some generic and some specialty | Ongoing, annually |
| New product margin threshold | 35% plus to qualify for Maharatna segment | Ongoing, per launch |
| H2 performance | Improve performance in both Q3 and Q4 | H2 FY26 |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Revenue from operations | ₹638 cr, +2% YoY |
| Gross profit | ₹220 cr, +11% YoY |
| EBITDA | ₹89 cr, flat YoY |
| PAT | ₹59 cr, -3% YoY |
| H1 EBITDA margin | 13% |
| B2C premium vs generic mix | 65% premium, 35% generic, vs 67%/33% in FY25 |
| Segment mix: B2C / B2B / Exports | 77% / 19% / 4%, vs 84%/14%/2% in Q2 FY25 |
| Sales returns | ~₹150 cr, vs ~₹100 cr in Q2 FY25, up 50% |
| Inventory | Crossed ₹700 cr mid-year; may rise to ₹800 cr for new season purchases |
| Crop advisors (CAs) deployed | ~1,200 at quarter-end, peaked at ~1,500 during season |
| Farmer outreach | Over 9,000 farmer meetings, over 5,000 demonstrations, reaching over 100,000 farmers in H1 |
| Kaeros PBT (H1) | ~₹7 cr |
| Kaeros gross sales (H1) | ~₹70 cr |
| H1 revenue growth | ~4% |
| Export full-year target | ₹150 cr, confident to achieve this year |